Holland Die Condition Monitor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Holland Die Condition Monitor


I Holland, the leading specialist manufacturer of tablet tooling for the pharmaceutical and nutraceutical industries, has recently launched the Holland Die Condition Monitor (HDCM).

HDCM is designed to monitor the condition of die bores, for any die type including multi-tips. When used at regular intervals it ensures that optimum life is achieved from dies and helps to prevent the production of damaged tablets.

A high accuracy probe is used, to measure the die bore wear (usually displayed  in the form of rings) and when used regularly it can help in the prediction  and planning of required expenditure on new die sets

HDCM can be fully integrated with I Holland’s Approve® system for a complete measurement solution, which incorporates tip diameter, barrel diameter, punch concentricity and die bore diameter.

When used as part of I Holland’s recommended PharmaCare® 7-Step Process, a professional punch and die maintenance and storage programme, HDCM assists punch and die users to ensure that critical tooling dimensions have stayed within tolerance following tool polishing or repair work, and helps to ensure proactive monitoring of tooling inventory.

 

I Holland

Website: www.iholland.co.uk

E-mail: clare.taylor@iholland.co.uk

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here